Dr. Mohamed Bouattour

Dr. Mohamed Bouattour

Overview

Dr. Mohamed Bouattour is a Medical Doctor at Beaujon University Hospital, holding this

position since November 2007. He is board certified in Gastroenterology, Hepatology and

Medical Oncology. He is currently serving as practitioner physician in the Department of

Digestive Oncology and Consultant Physician in the Department of Hepatology at Beaujon

Hopital.

Dr. Bouattour has expertise in the field of primary liver tumors; he is involved in preclinical

and clinical research for hepatocellular carcinoma and cholangiocarcinoma. He is a principal

investigator of several phase 1, 2 and 3 clinical trials for primary liver cancers.

Dr. Bouattour is involved in presenting several collaborative works in national and

international scientific meetings. He authored and co-authored scientific papers in the field of

liver and cancer diseases. He is member of several national and international societies such as

the EASL, AASLD, ILCA and ASCO.

Paris, France
French / English

Work Experience

Medical Doctor
Since 2007
Beaujon University Hospital

Pubmed

Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal.
2020
Clinics and research in hepatology and gastroenterology Read it here Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial.
2020
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Read it here Relevance of liver surface nodularity for preoperative risk assessment in patients with resectable hepatocellular carcinoma.
2020
The British journal of surgery Read it here

Professional Associations

The European associations for the study of the liver (EASL) Member American Association for the Study of Liver Diseases (AASLD) Member ILCA Member